Citation Select	Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, Elledge SJ, Niebuhr DW, Scher AI, Munger KL, Ascherio A Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis Science . 2022 Jan 21. doi: 10.1126/science.abj8222. Online ahead of print
Citation Select	MSF204 Investigators, Goodman AD, Brown TR, Edwards KR, Krupp LB, Schapiro RT, Cohen R, Marinucci LN, Blight AR A phase 3 trial of extended release oral dalfampridine in multiple sclerosis Ann Neurol. 2010 Oct;68(4):494-502
Citation Select	Hauser SL, Waubant E, Arnold DL, Vollmer T, Antel J, Fox RJ, Bar-Or A, Panzara M, Sarkar N, Agarwal S, Langer-Gould A, Smith CH, HERMES Trial Group HERMES Trial Group, B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med. 2008 Feb 14;358(7):676-88
Citation Select	Casetta I, Iuliano G, Filippini G Azathioprine for multiple sclerosis. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003982
Citation Select	International Natalizumab Multiple Sclerosis Trial Group; Miller DH, Khan OA, Sheremata WA, Blumhardt LD, Rice GPA, Libonati MA, Willmer-Hulme AJ, Dalton CM, Miszkiel KA, O'Connor PW A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis N Engl J Med. 2003 Jan 2;348(1):15-23
Citation Select	Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ, Simonian NA, Slasor PJ, Sandrock AW Intramuscular Interferon Beta-1a Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis N Engl J Med. 2000 Sep 28;343(13):898-904
Citation Select	PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis Lancet. 1998 Nov 7;352(9139):1498-504
Citation Select	European Study Group on interferon beta-1b in secondary progressive MS Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis Lancet. 1998 Nov 7;352(9139):1491-7
Citation Select	Sellebjerg F, Frederiksen JL, Nielsen PM, Olesen J Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS Neurology. 1998 Aug;51(2):529-34